Abstract
Purpose: Personalized information is paramount to patient-centered communication and decision-making regarding risk management in hereditary cancer syndromes. This systematic review identified information needs of individuals from families harboring BRCA pathogenic variants and compared findings based on gender (women vs men) and clinical characteristics (patients with cancer vs previvors and BRCA heterozygotes vs untested relatives). Methods: We screened 8115 studies identified from databases and citation searching. The quality of selected studies was assessed using the Mixed Methods Appraisal Tool. Narrative synthesis was conducted based on content analysis. Results: From 18 selected studies including 1063 individuals, we identified 9 categories of information needs. Risk of bias in the selected studies was moderate. Men, untested relatives, and racial and ethnic minorities were underrepresented. Frequently required information was personalized cancer risk and risk-reducing strategies, including decision-making, family implications of hereditary cancers, psychological issues, and cascade testing. Subgroup analyses showed that information needs depended on gender, personal cancer history, and cascade testing in relatives. Conclusion: We identified comprehensive and detailed informational needs of individuals from families harboring BRCA pathogenic variants and gaps in international guidelines. Needs for personalized information varied based on gender, health, and genetic testing status. Findings of this study have implications for genetic counseling, tailoring educational materials, and personalizing interventions.
Original language | English |
---|---|
Article number | 100001 |
Journal | Genetics in Medicine |
Volume | 25 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2023 Apr |
Bibliographical note
Funding Information:This research was supported by a grant by the Korean Health Technology R&D Project through the Korean Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare , Republic of Korea (grant number HI19C1330 ).
Funding Information:
This research was supported by a grant by the Korean Health Technology R&D Project through the Korean Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number HI19C1330). Conceptualization: S.Y.P. M.C.K.; Methodology: S.Y.P. M.C.K.; Formal Analysis: S.Y.P. Y.K.; Investigation: S.Y.P. Y.K.; Writing-original draft: S.Y.P.; Writing-review and editing: S.K. M.C.K.; Supervision: M.C.K.; Funding Acquisition: S.Y.P. This study did not include human subjects or animal research. The authors declare no conflicts of interest.
Publisher Copyright:
© 2022 The Authors
All Science Journal Classification (ASJC) codes
- Genetics(clinical)